Shows
Top Natural Tips¿Se puede reducir el riesgo de cáncer con la alimentación? Lo que dice la CienciaEn un artículo publicado en The Washington Post, el oncólogo Dr. Mikkael A. Sekeres, MD, explica que aunque el cáncer no siempre tiene una causa clara, la ciencia muestra que ciertos cambios en la alimentación pueden ayudar a reducir el riesgo.Más frutas y verduras, más granos integrales (que pueden disminuir hasta un 30% el riesgo de cáncer colorrectal), menos carnes procesadas y menos bebidas azucaradas.No se trata de extremos, sino de decisiones conscientes y sostenidas. La prevención empieza en lo cotidiano. 🌿✨
2026-02-2704 min
Top Natural Tips¿Se puede reducir el riesgo de cáncer con la alimentación? Lo que dice la CienciaEn un artículo publicado en The Washington Post, el oncólogo Dr. Mikkael A. Sekeres, MD, explica que aunque el cáncer no siempre tiene una causa clara, la ciencia muestra que ciertos cambios en la alimentación pueden ayudar a reducir el riesgo.Más frutas y verduras, más granos integrales (que pueden disminuir hasta un 30% el riesgo de cáncer colorrectal), menos carnes procesadas y menos bebidas azucaradas.No se trata de extremos, sino de decisiones conscientes y sostenidas. La prevención empieza en lo cotidiano. 🌿✨Support the show
2026-02-2704 min
Cancer Stories: The Art of OncologyMother's Grief: Loss Through the Lens of MotherhoodListen to JCO's Art of Oncology article, "Mother's Grief" by Dr. Margaret Cupit-Link, who is an assistant professor of pediatric hematology/oncology at Cardinal Glennon Children's Hospital of St. Louis University. The article is followed by an interview with Cupit-Link and host Dr. Mikkael Sekeres. Dr Cupit-Link shares a pediatric oncologist's experience of a patient's death through the new lens of motherhood. TRANSCRIPT AOO 26E03 Narrator: Mother's Grief, by Margaret Cupit-Link, MD, MSCI Mikkael Sekeres: Welcome back to JCO's Cancer Stories: The Art of Oncology. This ASCO podcast features intimate narratives...
2026-02-2430 min
Cancer Stories: The Art of OncologyMother's Grief: Loss Through the Lens of MotherhoodListen to JCO's Art of Oncology article, "Mother's Grief" by Dr. Margaret Cupit-Link, who is an assistant professor of pediatric hematology/oncology at Cardinal Glennon Children's Hospital of St. Louis University. The article is followed by an interview with Cupit-Link and host Dr. Mikkael Sekeres. Dr Cupit-Link shares a pediatric oncologist's experience of a patient's death through the new lens of motherhood. TRANSCRIPT AOO 26E03 Narrator: Mother's Grief, by Margaret Cupit-Link, MD, MSCI Mikkael Sekeres: Welcome back to JCO's Cancer Stories: The Art of Oncology. This ASCO podcast features intimate narratives...
2026-02-2430 min
Cancer Stories: The Art of OncologyNorth Star: The Importance of Presence in Pediatric OncologyListen now to the latest episode of JCO Cancer Stories: The Art of Oncology, North Star, by Dr Manuela Spadea. As a pediatric oncologist, Spadea shares a luminous, gut-honest reflection that reminds us that beyond protocols and outcomes, the deepest medicine is presence. TRANSCRIPT Narrator: North Star, by Manuela Spadea, MD Mikkael Sekeres: Welcome back to JCO's Cancer Stories: The Art of Oncology. This ASCO podcast features intimate narratives and perspectives from authors exploring their experiences in oncology. I am your host, Mikkael Sekeres. I am professor of medicine and Chief of the...
2026-02-1024 min
English - The Bloodline with Blood Cancer United PodcastThe Bloodline Live! Myelodysplastic Syndromes (MDS) Updates in ResearchMikkael A. Sekeres, MD, MS
Curious about what’s new in the world of myelodysplastic syndromes (MDS)? We’re bringing you the latest insights straight from one of the field’s leading experts.
In this episode, we speak with Dr. Mikkael Sekeres, of the Sylvester Comprehensive Cancer Center at University of Miami Health. Recorded onsite at the 2025 ASH (American Society of Hematology) Annual Meeting and Exposition, this conversation explores what MDS is, how it’s treated today, and what researchers are learning about managing side effects.
Dr. Sekeres also walks us through the most notable MDS upda...
2026-01-2918 minEpisodes - The Bloodline with Blood Cancer United PodcastThe Bloodline Live! Myelodysplastic Syndromes (MDS) Updates in ResearchMikkael A. Sekeres, MD, MS
Curious about what’s new in the world of myelodysplastic syndromes (MDS)? We’re bringing you the latest insights straight from one of the field’s leading experts.
In this episode, we speak with Dr. Mikkael Sekeres, of the Sylvester Comprehensive Cancer Center at University of Miami Health. Recorded onsite at the 2025 ASH (American Society of Hematology) Annual Meeting and Exposition, this conversation explores what MDS is, how it’s treated today, and what researchers are learning about managing side effects.
Dr. Sekeres also walks us through the most notable MDS upda...
2026-01-2918 minLeukemia - The Bloodline with Blood Cancer United PodcastThe Bloodline Live! Myelodysplastic Syndromes (MDS) Updates in ResearchMikkael A. Sekeres, MD, MS
Curious about what’s new in the world of myelodysplastic syndromes (MDS)? We’re bringing you the latest insights straight from one of the field’s leading experts.
In this episode, we speak with Dr. Mikkael Sekeres, of the Sylvester Comprehensive Cancer Center at University of Miami Health. Recorded onsite at the 2025 ASH (American Society of Hematology) Annual Meeting and Exposition, this conversation explores what MDS is, how it’s treated today, and what researchers are learning about managing side effects.
Dr. Sekeres also walks us through the most notable MDS upda...
2026-01-2918 minTreatment - The Bloodline with Blood Cancer United PodcastThe Bloodline Live! Myelodysplastic Syndromes (MDS) Updates in ResearchMikkael A. Sekeres, MD, MS
Curious about what’s new in the world of myelodysplastic syndromes (MDS)? We’re bringing you the latest insights straight from one of the field’s leading experts.
In this episode, we speak with Dr. Mikkael Sekeres, of the Sylvester Comprehensive Cancer Center at University of Miami Health. Recorded onsite at the 2025 ASH (American Society of Hematology) Annual Meeting and Exposition, this conversation explores what MDS is, how it’s treated today, and what researchers are learning about managing side effects.
Dr. Sekeres also walks us through the most notable MDS upda...
2026-01-2918 minThe Bloodline with Blood Cancer United PodcastThe Bloodline Live! Myelodysplastic Syndromes (MDS) Updates in ResearchMikkael A. Sekeres, MD, MS
Curious about what’s new in the world of myelodysplastic syndromes (MDS)? We’re bringing you the latest insights straight from one of the field’s leading experts.
In this episode, we speak with Dr. Mikkael Sekeres, of the Sylvester Comprehensive Cancer Center at University of Miami Health. Recorded onsite at the 2025 ASH (American Society of Hematology) Annual Meeting and Exposition, this conversation explores what MDS is, how it’s treated today, and what researchers are learning about managing side effects.
Dr. Sekeres also walks us through the most notable MDS upda...
2026-01-2918 min
Cancer Stories: The Art of OncologyA Chance to Heal with Cold Hard Steel: The Fine Surgical Line Between Healing and HarmingListen to JCO's Art of Oncology article, "A Chance to Heal with Cold Hard Steel" by Dr. Taylor Goodstein, who is a fellow at Emory University. The article is followed by an interview with Goodstein and host Dr. Mikkael Sekeres. Dr. Goodstein shares a story about surgery, grief, and being courageous in the face of one's own fallibility. TRANSCRIPT Narrator: A Chance to Heal with Cold Hard Steel, Taylor Goodstein, MD Mikkael Sekeres: Welcome back to JCO's Cancer Stories: The Art of Oncology. This ASCO podcast features intimate narratives and perspectives from authors...
2026-01-2730 min
Cancer Stories: The Art of OncologyThe Quiet Work of Clarity: Seeing Into the Future at the End of LifeListen to JCO's Art of Oncology article, "The Quiet Work of Clarity" by Dr. Henry Bair, who is an ophthalmology resident physician at Wills Eye Hospital. The article is followed by an interview with Bair and host Dr. Mikkael Sekeres. Dr. Bair explores how vision care can honor end-of-life goals and helps a patient with failing sight write to his children. TRANSCRIPT Narrator: The Quiet Work of Clarity, Henry, Bair, MD Mikkael Sekeres: Welcome back to JCO's Cancer Stories: The Art of Oncology. This ASCO podcast features intimate narratives and perspectives from authors...
2026-01-1329 minCancer Stories: The Art of OncologyFinal Silence: The Weight of Unspoken WordsListen to JCO's Art of Oncology article, "Final Silence" by Dr. Ju Won Kim, who is an Assistant Professor at Korea University College of Medicine, Medical Oncology. The article is followed by an interview with Kim and host Dr. Mikkael Sekeres. Dr Kim explores the burden of silence when caring for dying patients. TRANSCRIPT Narrator: Final Silence, by Ju Won Kim Dr. Mikkael Sekeres: Welcome back to JCO's Cancer Stories: The Art of Oncology. This ASCO podcast features intimate narratives and perspectives from authors exploring their experiences in oncology. I'm your host, Mikkael...
2025-12-2326 min
Medical Digest & Congress ReportMyelodysplastic Syndrome Highlights from ASH 2025Mikkael A. Sekeres discusses the state of the art treatment in myelodysplastic syndrome at the American Society of Hematology's 67th Annual Meeting.Video: https://medicaldigest.org/scientific-contents/interview:myelodysplastic-syndrome-highlights-ash-2025
2025-12-1805 minCancer Stories: The Art of OncologySmell: The Scent of InevitabilityListen to JCO's Art of Oncology article, "Smell," by Dr. Alice Cusick, who is a Hematology Section Chief at Veterans Affairs Ann Arbor Health System and Assistant Professor at the University of Michigan Division of Hematology and Oncology. The article is followed by an interview with Cusick and host Dr. Mikkael Sekeres. Dr Cusick shares a connection to a cancer patient manifested as a scent. TRANSCRIPT Narrator: Smell, by Alice Cusick, MD Dr. Mikkael Sekeres: Welcome back to JCO's Cancer Stories: The Art of Oncology. This ASCO podcast features intimate narratives and perspectives...
2025-12-0923 min
The Cancer LetterOncofertility has been an overlooked standard of care—now states are taking actionRecently, a wave of new private insurance mandates have swept the nation making fertility preservation a covered benefit for people with cancer in 21 states plus Washington, DC. Mia Sandino, an osteosarcoma survivor, chose not to undergo fertility preservation when she was diagnosed at 19. She didn’t know if she wanted kids, had no guarantee that her insurance would cover the extraordinary costs, and feared postponing treatment would delay her return to "normal life."This episode is available on Spotify, Apple Podcasts, and YouTube.On this week’s episode of The Cancer Letter Podcast, Sara...
2025-11-2619 minCancer Stories: The Art of OncologyAre You Bereaved? Allowing Yourself to Grieve a PatientListen to JCO's Art of Oncology article, "Are You Bereaved?" by Dr. Trisha Paul, who is an Assistant Professor in Pediatric Hematology/ Oncology and Palliative Care at University of Rochester Medical Center. The article is followed by an interview with Paul and host Dr. Mikkael Sekeres. Dr Paul reflects on a grieving father's question about her own bereavement. TRANSCRIPT Narrator: Are You Bereaved?, by Trisha Paul, MD, MFA Dr. Mikkael Sekeres: Welcome back to JCO's Cancer Stories: The Art of Oncology. This ASCO podcast features intimate narratives and perspectives from authors exploring their...
2025-11-2521 minCancer Stories: The Art of OncologyThe Man at the Bow: Remembering the Lives People Lived Prior to CancerListen to JCO's Art of Oncology article, "The Man at the Bow" by Dr. Alexis Drutchas, who is a palliative care physician at Dana Farber Cancer Institute. The article is followed by an interview with Drutchas and host Dr. Mikkael Sekeres. Dr. Drutchas shares the deep connection she had with a patient, a former barge captain, who often sailed the same route that her family's shipping container did when they moved overseas many times while she was growing up. She reflects on the nature of loss and dignity, and how oncologists might hold patients' humanity with more tenderness and...
2025-11-1126 minCancer Stories: The Art of OncologyReflection: When Cancer Affects a Family MemberListen to JCO's Art of Oncology article, "Reflection" by Dr. Jamie Riches, who is an Assistant Professor at Columbia University and Director of the Hematology Oncology Hospitalist Service. The article is followed by an interview with Riches and host Dr. Mikkael Sekeres. Dr Riches shares a deeply personal narrative, reflecting on the profound personal and professional impact of losing her young family member to cancer, illuminating the intimate intersection of grief, loss, and healing. TRANSCRIPT Narrator: Reflection, by Jaime C. Riches, DO If I stand this way, with my shoulders back, my chin...
2025-10-3020 minCancer Stories: The Art of OncologyA Fight Bigger than Myeloma: Race Relations and Bias in MedicineListen to JCO's Art of Oncology article, "A Fight Bigger Than Myeloma" by Dr. Adeel Khan, an Assistant Professor of Medicine and Public Health at UT Southwestern. The article is followed by an interview with Dr. Adeel Khan and host Dr. Mikkael Sekeres. Dr. Khan shares the story of a patient whose multiple myeloma diagnosis and treatment serves as a reminder of the civil liberties progress we've made and that we have more to go. TRANSCRIPT Narrator: A Fighter Bigger Than Myeloma, by Adeel M. Khan, MD, MPH, MS I met her during...
2025-10-1425 minCancer Stories: The Art of OncologyWhispers After the Cure: Reflections on Marriage and Malignancy in IndiaListen to JCO Global Oncology's Art of Global Oncology article, "Whispers After the Cure: Reflections on Marriage and Malignancy in India" by Dr. Vangipuram Harshil Sai, who is a fourth semester medical student at All India Institute of Medical Sciences. The article is followed by an interview with Harshil Sai and host Dr. Mikkael Sekeres. Sai shares his personal reflection of a visit which transformed into an education in silence, stigma, and the unseen aftermath of survivorship for young women in India. TRANSCRIPT Narrator: Whispers After the Cure: Reflections on Marriage and Malignancy in India...
2025-10-0923 minCancer Stories: The Art of OncologyBrown Paper Bags: Beware of Patients Bearing GiftsListen to ASCO's Journal of Clinical Oncology Art of Oncology article, "Brown Paper Bags" by Dr. Stephanie Graff, who is an Associate Professor of Medicine at Brown University and Director of Breast Oncology at Brown University Health in Providence Rhode Island. The article is followed by an interview with Graff and host Dr. Mikkael Sekeres. Dr Graff shares how she handled receiving a gift from a patient. TRANSCRIPT Narrator: Brown Paper Bags, by Stephanie Graff, MD, FACP, FASCO Minor demographic features of the patients described have been altered to honor their privacy
2025-09-1230 minCancer Stories: The Art of OncologyNo Versus Know: Patient Empowerment Through Shared Decision MakingListen to ASCO's JCO Oncology Practice Art of Oncology article, "No Versus Know: Patient Empowerment Through Shared Decision Making" by Dr. Beatrice Preti, who is an Assistant Professor at Emory University. The article is followed by an interview with Preti and host Dr. Mikkael Sekeres. Dr Preti explores the challenges which may prevent oncologists from fully engaging with patients during shared decision making. TRANSCRIPT Narrator: No Versus Know: Patient Empowerment Through Shared Decision Making, by Beatrice T.B. Preti, MD, MMed, FRCPC During a recent clinic, I saw three patients back-to-back, all from...
2025-09-0228 min
Post ReportsWhat an oncologist wants us to know about everyday chemicalsEndocrine disruptors are chemicals that can interfere with the complex system that produces and interacts with our hormones. Research suggests they can affect the reproductive system, our kidneys, and even increase our risk of cancer. There are over 1,000 types of endocrine-disrupting chemicals, according to some estimates, and we are exposed to them daily through things like kitchen utensils and makeup. So how worried should we be about inevitable exposure?Host Elahe Izadi speaks with oncologist Dr. Mikkael Sekeres about the connection between endocrine disruptors and cancer. Dr. Sekeres also shares his advice on steps he takes to...
2025-08-0626 min
ALL IN Miami40% of Cancers Are Preventable - Here’s HowCancer touches all of us. Over 1 in 5 people will face it in their lifetime—so what if I told you nearly 40% of those cases are preventable?
In this episode, inspired by oncologist Dr. Mikkael Sekeres (whose own family inspired his research), we share 11 science-backed ways to reduce your cancer risk. This isn’t medical jargon—it’s real, practical steps you can start today. As you probably know, I'm not a doctor, so make sure to do your own research and due diligence.
You’ll learn why:
Eating fruits, veggies, w...
2025-07-1426 minCancer Stories: The Art of OncologyTranscription: Phone Call, 2018: A Mother's Love in IllnessListen to Journal of Clinical Oncology's Art of Oncology poem, "Transcription: Phone Call, 2018" by Elane Kim, a student at Harvard College. The poem is followed by an interview with Kim and host Dr. Mikkael Sekeres. Kim shares her poem that lingers in the spaces between words; a mother and daughter navigating illness and memory. TRANSCRIPT Narrator: Transcription: Phone Call, 2018, by Elane Kim Spiculated mass, irregular contours. Can you come to translate these words? Something in the lung. Yes, I am eating well. Birds, green ones...
2025-06-2419 minCancer Stories: The Art of OncologyA Whipple of Choice: Choosing Between Debilitating Surgery or Watchful WaitingListen to ASCO's Journal of Clinical Oncology Art of Oncology article, "A Whipple of Choice" by Dr. Carl Forsberg, who is an Assistant Professor of Strategy and History at Air Force War College. The article is followed by an interview with Forsberg and host Dr. Mikkael Sekeres. Dr Forsberg shares his experience with an uncommon cancer treated by a new therapy for which no directly relevant data were available. Transcript Narrator: A Whipple of Choice, by C. W. Forsberg, PDH I sat across from a hepatobiliary surgeon on a gray October afternoon. "To be frank,"...
2025-06-1030 minCancer Stories: The Art of OncologyAn Oncologist's Guide to Ensuring Your First Medical Grand Rounds Will Be Your Last: Lessons on How NOT to Induce Coma in Your AudienceListen to ASCO's JCO Oncology Practice, Art of Oncology Practice article, "An Oncologist's Guide to Ensuring Your First Medical Grand Rounds Will Be Your Last" by Dr. David Johnson, who is a clinical oncologist at University of Texas Southwestern Medical School. The article is followed by an interview with Johnson and host Dr. Mikkael Sekeres. Through humor and irony, Johnson critiques how overspecialization and poor presentation practices have eroded what was once internal medicine's premier educational forum. Transcript Narrator: An Oncologist's Guide to Ensuring Your First Medical Grand Rounds Will Be Your Last, by David H. Johnson...
2025-05-1327 min
Treating Blood CancersMDS: Patient-Centered Approaches to Diagnosis and Treatment
Mikkael A. Sekeres, MD, MS, University of Miami Sylvester Comprehensive Cancer Center, Miami, FL
Recorded on April 17, 2025
Mikkael A. Sekeres, MD, MS
Chief, Division of Hematology
Professor of Medicine
Sylvester Comprehensive Cancer Center
University of Miami
Miami, FL
Join us with Dr. Mikkael Sekeres of the University of Miami Sylvester Comprehensive Cancer Center as he explores the complexities of diagnosing and treating Myelodysplastic Syndromes (MDS), including “watch and wait.” Through case-based discussion, he highlights advances in high-risk MDS management, from novel targeted therapies to stem cell transplantation and...
2025-04-3042 minCancer Stories: The Art of OncologyWriting a Medical Memoir: Lessons From a Long, Steep RoadListen to ASCO's Journal of Clinical Oncology Art of Oncology article, "Writing a Medical Memoir: Lessons From a Long, Steep Road" by David Marks, consultant at University Hospitals Bristol NHS Foundation Trust. The article is followed by an interview with Marks and host Dr. Mikkael Sekeres. Marks shares his challenging journey of writing a memoir describing his patients and career. Transcript Narrator: Writing a Medical Memoir: Lessons From a Long, Steep Road, by David Marks, PhD, MBBS, FRACP, FRCPath The purpose of this essay is to take hematologist/oncologist readers of the Journal on my...
2025-04-2229 minCancer Stories: The Art of OncologyTamales: Celebrating a Mexican Christmas TraditionListen to ASCO's Journal of Clinical Oncology Art of Oncology article, "Tamales" by Megan Dupuis, an Assistant Professor of Hematology and Oncology at Vanderbilt University Medical Center. The article is followed by an interview with Dupuis and host Dr. Mikkael Sekeres. Dupuis reflects on how patients invite their doctors into their culture and their world- and how this solidified her choice to be an oncologist. TRANSCRIPT Narrator: Tamales, by Megan Dupuis, MD, PhDI do not know if you know this, but tamales are an important—nay, critical—part of the Mexican Christmas tradition. Befo...
2025-04-1027 minCancer Stories: The Art of OncologyThe First Hero: A Son Reflects on His Father's IllnessListen to ASCO's Journal of Clinical Oncology Art of Oncology poem, "The First Hero" by Christopher Kim, who is a research assistant at Institute for Stem Cell Biology and Regenerative Medicine at Stanford University. The poem is followed by an interview with Kim and host Dr. Mikkael Sekeres. Kim reflects on his post-surgery sonnet. TRANSCRIPT Narrator: The First Hero, by Christopher Kim, BS When he is like this—eyes closed, face still— he is unfamiliar. He wears a face younger than usual; fragile limbs washed in fluorescent ligh...
2025-03-2516 minCancer Stories: The Art of OncologyI Hope So Too: Creating Space to Hope with Patients and FamiliesListen to ASCO's Journal of Clinical Oncology Art of Oncology article, "I Hope So Too" by Dr. Richard Leiter from Dana-Farber Cancer Institute. The article is followed by an interview with Leiter and host Dr. Mikkael Sekeres. Leiter shares that even in the most difficult moments, clinicians can find space to hope with patients and their families. TRANSCRIPT Narrator: I Hope So Too, by Richard E. Leiter, MD, MA "You're always the negative one," Carlos' mother said through our hospital's Spanish interpreter. "You want him to die." Carlos was 21...
2025-03-1324 minCancer Stories: The Art of OncologyYou Don't Bring Me Flowers: Hospital Policy vs. Patient JoyListen to ASCO's Journal of Clinical Oncology Art of Oncology article, "You Don't Bring Me Flowers" by Dr. Kathryn Cappell, who is an Assistant Research Physician at the National Cancer Institute. The article is followed by an interview with Cappell and host Dr. Mikkael Sekeres. Dr Cappell shares the difficulty in protecting oncology patients without taking away things that bring them joy. TRANSCRIPT Narrator: You Don't Bring Me Flowers, by Kathryn Cappell, MD, PhD Easter morning dawned a beautiful spring day in Washington, DC. Soft sunlight and a cool breeze streamed through my...
2025-01-2820 minCancer Stories: The Art of OncologyHost Transition: Meet Cancer Stories New Host Dr. Mikkael SekeresWe say thank you to current Cancer Stories host, Dr. Lidia Schapira, and welcome Cancer Stories new host, Dr. Mikkael Sekeres. TRANSCRIPT Dr. Lidia Schapira: Hello and welcome to JCO's Cancer Stories: The Art of Oncology, which features essays and personal reflections from authors exploring their experience in the field of oncology. I'm your host, Dr. Lidia Schapira, a Professor of Medicine at Stanford University, and with me today is Dr. Mikkael Sekeres, who is a Professor of Medicine and the Chief of the Division of Hematology at the Sylvester Comprehensive Cancer Center in Miami...
2025-01-1419 minMedical Digest & Congress ReportState of the Art Treatment in Myelodysplastic Syndromes - report from ASH2024Mikkael A. Sekeres, MD, MS discusses the state of the art treatment in MDS at the 2024 ASH Annual Meeting.
Video: https://medicaldigest.org/scientific-contents/interview:state-art-treatment-myelodysplastic-syndromes
2024-12-2005 min
Oncology Brothers: Practice-Changing Cancer DiscussionsHow to Approach to Acute Myeloid Leukemia (AML) from Community Oncology PerspectiveIn this episode of the Oncology Brothers podcast, hosts Drs. Rahul and Rohit Gosain are joined by Dr. Mikkael Sekeres, Professor of Medicine and Chief of the Division of Hematology at the University of Miami. Together, they explore the complex landscape of acute myeloid leukemia (AML), discussing the latest advancements in diagnosis, treatment options, and risk stratification.
Key topics included:
• The importance of molecular testing in AML diagnosis and treatment planning
• The role of intensive induction chemotherapy and the classic 7+3 regimen
• New oral therapies, including FLT3 inhibitors and hypomethylating agents combined with venetoclax
2024-10-1322 min
Story in the Public SquareA Closer Look at Drugs and the FDA with Mikkael SekeresIn 2011, the Food and Drug Administration held a hearing to review a drug previously approved for the treatment of metastatic breast cancer. The hearing was fraught with concerns over the drug’s safety competing with cancer patients who felt they were alive because of the drug. Dr. Mikkael Sekeres was on the panel receiving testimony, and weighing what he heard against the long history of the FDA to make sure drugs are safe AND effective. Mikkael Sekeres is a professor of medicine and chief of the division of Hematology at the Sylvester Comprehensive Cancer Center, University of Mi...
2024-07-0927 min
The HemOnc Pulse‘The HemOnc Pulse’ Live 2024: Unanswered Questions in CML TreatmentRecorded at the first “HemOnc Pulse” Live meeting in Chicago, this podcast episode features a panel discussion on unanswered questions in chronic myeloid leukemia (CML) with Elias Jabbour, MD, a Professor of Medicine in the Department of Leukemia at the University of Texas MD Anderson Cancer Center; Mikkael Sekeres, MD, MS, a Professor of Medicine and Chief of the Division of Hematology at the University of Miami Sylvester Comprehensive Cancer Center; and Sangeetha Venugopal, MD, MS, an Assistant Professor of Medicine at the Sylvester Comprehensive Cancer Center.
2024-05-2128 minThe HemOnc Pulse"The HemOnc Pulse" Live 2024 in Chicago: AML Unanswered Questions"The HemOnc Pulse" goes on the road to Chicago with host Chadi Nabhan, MD, MBA, FACP.
This podcast episode features a panel discussion on unanswered questions in acute myeloid leukemia (AML) with Naval Daver, MD, an Associate Professor in the Department of Leukemia at the University of Texas MD Anderson Cancer Center; Sanam Loghavi, MD, of the MD Anderson Cancer Center; Rami Komrokji, MD, the Vice-Chair of the Malignant Hematology Department at Moffitt Cancer Center in Tampa, Florida; and Mikkael Sekeres, MD, MS, a Professor of Medicine and Chief of the Division of Hematology at the Sylvester...
2024-05-0434 min
Live Longer WorldFDA History and Breast Cancer Drug Controversy | Dr. Mikkael SekeresDr. Mikkael Sekeres is the author of the book The Drugs and FDA. He served as the chair of the Oncology Drugs Advisory Committee of the FDA, and was on the jury for the controversial trial of the breast cancer drug Avastin.
We discuss:
- The history of the FDA,
- The trial of Avastin which got FDA approval in 2008 and revoked in 2011
- FDA's funding mechanisms
- FDA ties to big pharma
- What can be improved about the FDA and the criticisms it receives
Episode Show Notes: https://livelongerworld.com/p/msekeres
TIMESTAMPS:
0:00 Surprising finding...
2024-04-241h 05Medical Digest & Congress ReportHighlights of the ASH 2023 CongressProfessor Mikkael Sekeres summarizes the most important highlights that presented at the 65th American Society of Hematology Annual Meeting.
Video: https://medicaldigest.org/scientific-contents/interview:highlights-ash-2023-congress
2023-12-2109 min
Inside U Miami MedicineBlood Cancer: CAR-T Cell Therapy and Targeted TreatmentsBecause of complex genetic mutations, treating blood cancers
is particularly challenging and requires specialized therapies. In the intricate world of leukemia, lymphoma and myeloma, each breakthrough achieved through clinical trials brings scientists and clinicians a step closer to transforming standards of care for patients around the world.
Dr. Mikkael Sekeres, chief of the Division of Hematology at the Sylvester Comprehensive Cancer Center, provides insight into these diseases and shares the current research landscape in the latest episode of Inside U Miami Medicine.
2023-12-0630 minInside U Miami MedicineA cancer doctor embraces vulnerability in healing“You shouldn’t have to compromise any aspect of your humanity to be a physician.” Dr. Mikkael Sekeres, a world-renowned hematologist at Sylvester Comprehensive Cancer Center, is fighting for providers to preserve the vulnerability and humanity that initially inspired them to embark on their journey in medicine. Listen in as he and Dean Henri Ford explore important topics like physician burnout, patient communication and more on the latest episode of Inside U Miami Medicine.
2023-11-2242 min
The Smartest Doctor in the RoomEp. 120 - Can Your Cancer Diagnosis be Wrong?Dr. Mikkael Sekeres, is the chief of hematology at the University of Miami's Sylvester Comprehensive Cancer Center. We discuss his book " When Blood Breaks Down-Life Lessons from Leukemia." He gives great insight on what should you do if diagnosed with a blood cancer.
2023-11-0749 min
Unbiased ScienceThe FDA: A Spoonful of Safety Makes The Medicine Go DownOn this week's episode of the pod, we are talking about a drug that's been available for decades but is suddenly being pulled from shelves: phenylephrine (something you've probably reached for when you've been congested). We bring on an expert, Dr. Mikkael Sekeres, a Professor of Medicine and Chief of the Division of Hematology at the Sylvester Comprehensive Cancer Center at the University of Miami who formerly chaired the Oncologic Drugs Advisory Committee of the FDA. Dr. Sekeres helps us walk through the history of the FDA's regulation of the safety and effectiveness of drugs. We discuss some other...
2023-10-2552 min
Healthcare UnfilteredEpisode 152: ASH Position on the ABIM MOC With Robert Brodsky and Mikkael SekeresChadi is joined by Dr. Robert Brodsky, President of ASH, and Dr. Mikkael Sekeres, Chair of Communications at ASH, to discuss what led to the recent ASH statement on the ABIM MOC and to gather their reactions to the ABIM response and to what next steps might look like. The guests detail the relationship and progress made between ASH and ABIM since the beginning of the partnership in 2001, the process involved for ASH to eventually release a letter related to the MOC, the contents of the letter, the ABIM’s response to the letter, and next steps needed to ma...
2023-10-241h 08
AAMDSIF Podcasts for PatientsThe Importance of Getting Second Opinion with Dr. Mikkael SekeresDr. Mikkael Sekeres describes why patients should request a second opinion about their bone marrow failure disease or blood cancer. He also shares his own perspective about asking for a second opinion, recommending that patients do select this option.
#MDS #aplasticanemia #bonemarrowfailure #bloodcancer
2023-09-1512 min
Blood Cancer TalksEpisode 22. Management of Low-Risk MDSIn this episode, we take a deep dive into low-risk MDS management. We have the privilege of being joined by the esteemed Dr. Mikkael Sekeres. We also explore his invaluable insights gained from his time at FDA ODAC and his latest literary endeavor, "Drugs and the FDA". Here are the key studies discussed:1. ASH choosing wisely: https://www.hematology.org/education/clinicians/guidelines-and-quality-care/choosing-wisely 2. International Consensus Classification (ICC): https://pubmed.ncbi.nlm.nih.gov/35767897/ 3. WHO classification 2022: https://pubmed.ncbi.nlm.nih.gov/35732829/ 4. I...
2023-05-201h 03
New Books in MedicinePharmacological Histories Ep. 2: Mikkael A. Sekeres on the Drugs Fighting LeukemiaThis episode offers an insight into the work of leading cancer specialist and author of When Blood Breaks Down, Mikkael A. Sekeres. 1 in 2 people will develop cancer in their lifetime, but thankfully treatment for the disease is rapidly changing and improving. I ask Mikkael about the drugs that allow people to beat cancer and live better with it.When you are told that you have leukemia, your world stops. Your brain can't function. You are asked to make decisions about treatment almost immediately, when you are not in your right mind. And yet you pull yourself together an...
2023-05-1133 min
New Books in Biology and EvolutionPharmacological Histories Ep. 2: Mikkael A. Sekeres on the Drugs Fighting LeukemiaThis episode offers an insight into the work of leading cancer specialist and author of When Blood Breaks Down, Mikkael A. Sekeres. 1 in 2 people will develop cancer in their lifetime, but thankfully treatment for the disease is rapidly changing and improving. I ask Mikkael about the drugs that allow people to beat cancer and live better with it.When you are told that you have leukemia, your world stops. Your brain can't function. You are asked to make decisions about treatment almost immediately, when you are not in your right mind. And yet you pull yourself together an...
2023-05-0933 min
New Books in SciencePharmacological Histories Ep. 2: Mikkael A. Sekeres on the Drugs Fighting LeukemiaThis episode offers an insight into the work of leading cancer specialist and author of When Blood Breaks Down, Mikkael A. Sekeres. 1 in 2 people will develop cancer in their lifetime, but thankfully treatment for the disease is rapidly changing and improving. I ask Mikkael about the drugs that allow people to beat cancer and live better with it.When you are told that you have leukemia, your world stops. Your brain can't function. You are asked to make decisions about treatment almost immediately, when you are not in your right mind. And yet you pull yourself together an...
2023-05-0933 min
The MIT Press PodcastPharmacological Histories Ep. 2: Mikkael A. Sekeres on the Drugs Fighting LeukemiaThis episode offers an insight into the work of leading cancer specialist and author of When Blood Breaks Down, Mikkael A. Sekeres. 1 in 2 people will develop cancer in their lifetime, but thankfully treatment for the disease is rapidly changing and improving. I ask Mikkael about the drugs that allow people to beat cancer and live better with it.When you are told that you have leukemia, your world stops. Your brain can't function. You are asked to make decisions about treatment almost immediately, when you are not in your right mind. And yet you pull yourself together an...
2023-05-0933 min
Listen To The Full Audiobook That Keeps Book-Lovers Hooked.Drugs and the FDA by Mikkael A. SekeresPlease visithttps://thebookvoice.com/podcasts/2/audible/45611to listen full audiobooks.
Title: Drugs and the FDA
Author: Mikkael A. Sekeres
Narrator: Mike Lenz
Format: mp3
Length: 8 hrs and 40 mins
Release date: 04-11-23
Ratings: 4.5 out of 5 stars, 6 ratings
Genres: Law
Publisher's Summary:
Food and Drug Administration approval for COVID-19 vaccines and the controversial Alzheimer's drug Aduhelm made headlines, but few of us know much about how the agency does its work. Why is the FDA the ultimate United States authority on a drug's safety and efficacy? In Drugs and the FDA, Mikkael Sekeres—a leading oncologist and former chair of the FD...
2023-04-118h 40Step Inside An Mind-Blowing Full Audiobook And Elevate Your Mindset.Drugs and the FDA by Mikkael A. SekeresPlease visithttps://thebookvoice.com/podcasts/2/audible/23907to listen full audiobooks.
Title: Drugs and the FDA
Author: Mikkael A. Sekeres
Narrator: Mike Lenz
Format: mp3
Length: 8 hrs and 40 mins
Release date: 04-11-23
Ratings: 4.5 out of 5 stars, 6 ratings
Genres: Medicine & Health Care Industry
Publisher's Summary:
Food and Drug Administration approval for COVID-19 vaccines and the controversial Alzheimer's drug Aduhelm made headlines, but few of us know much about how the agency does its work. Why is the FDA the ultimate United States authority on a drug's safety and efficacy? In Drugs and the FDA, Mikkael Sekeres—a leading oncologist and former ch...
2023-04-118h 40
the Essential Free Audiobooks in Non-Fiction, Current Affairs, Law, & PoliticsDrugs and the FDA: Safety, Efficacy, and the Public's Trust by Mikkael A. SekeresPlease visit https://thebookvoice.com/podcasts/1/audiobook/649571 to listen full audiobooks. Title: Drugs and the FDA: Safety, Efficacy, and the Public's Trust Author: Mikkael A. Sekeres Narrator: Mike Lenz Format: Unabridged Audiobook Length: 8 hours 40 minutes Release date: April 11, 2023 Genres: Current Affairs, Law, & Politics Publisher's Summary: Food and Drug Administration approval for COVID-19 vaccines and the controversial Alzheimer's drug Aduhelm made headlines, but few of us know much about how the agency does its work. Why is the FDA the ultimate United States authority on a drug's safety and efficacy? In Drugs and the FDA, Mikkael Sekeres—a leading oncologist and fo...
2023-04-1130 min
Healthcare UnfilteredEpisode 127: “Toxic Exposure” Review With Kelly Ryerson and Mikkael SekeresIn a change-of-pace episode, Chadi has the tables turned on him as he is interviewed by two supporters and reviewers of his new book “Toxic Exposure: The True Story behind the Monsanto Trials and the Search for Justice.” Kelly Ryerson, MBA, GlyphosateGirl.com, and Mikkael Sekeres, author of “Drugs and the FDA: Safety, Efficacy, and the Public's Trust” and “When Blood Breaks Down: Life Lessons from Leukemia,” ask Chadi to comment on why he was chosen as an expert witness, how glyphosate causes cancer and how much exposure is needed to cause lymphoma, why Roundup is able to stay on the marke...
2023-04-0456 min
This is DemocracyThis is Democracy – Episode 232: FDA and Public HealthMikkael Sekeres is a Professor of Medicine and Chief of the Division of Hematology at the Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine. Dr. Sekeres has published hundreds of scholarly and Op-Ed articles, and he is the author of 8 books, including: When Blood Breaks Down: Life Lessons from Leukemia (The MIT Press 2020) and most recently, Drugs and the FDA: Safety, Efficacy, and the Public’s Trust (The MIT Press 2022).
2023-03-3034 min
The PQI PodcastSeason 4, Ep. 1 : Drugs and the FDA with Dr. Mikkael SekeresSeason 4 Episode 1- Drugs and the FDA with Dr. Mikkael Sekeres This week we sit down with Dr. Mikkael Sekeres to discuss his latest book Drugs and the FDA. Dr. Sekeres is Professor of Medicine and Chief of the Division of Hematology at the Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, and former Chair of the Oncologic Drugs Advisory Committee of the FDA. A regular contributor to the Well section of the New York Times, he is the author of When Blood Breaks Down: Life Lessons from Leukemia (MIT Press). More i...
2023-01-1938 min
The DemystifySci PodcastDeath, Drugs, & Corruption at the FDA - Dr. Mikkael Sekeres, University of MiamiWhat happens when the FDA approves a drug that doesn't work? Say it gets accelerated approval from the regulatory body, but further clinical trials demonstrate a lack of efficacy. Normally, the agency requests that the company take their drug off the market, the company does so, and so the wheel turns. But when post-approval clinical trials showed that Genentech's blockbuster breast cancer drug Avastin was killing women, the company broke with more than a century of tradition, and declined to take their drug off the market. We talk with Miami University's Mikkael Sekeres about his experience sitting on the...
2023-01-122h 04
Book Society@MikkaelSekeres and I talk about the fascinating history of the Food and Drug Administration and how Vaccines, i.e. COVID, get approved quickly.Dr. Mikkael Sekeres and I talk about the fascinating history of the Food and Drug Administration and how Vaccines, i.e. COVID, get approved quickly. We also talk about how billions of dollars and regulatory loopholes can result in ineffective drugs staying on the market. We also talk about what people do when they find out they have cancer.Buy Drugs and the FDA:https://www.amazon.com/Drugs-FDA-Safety-Efficacy-Publics/dp/0262047314/ref=sr_1_1?crid=2MK66OVU81U71&keywords=drugs+and+the+fda&qid=1670615780&sprefix=drugs+and+the+fda%2Caps%2C124&sr=8-1Here's a re...
2022-12-0936 min
Book Society@MikkaelSekeres and I discuss The Brief And Wondrous Life of Oscar WaoDr. Mikkael Sekeres can talk at length about ideas and literature. He can also cure cancer.
2022-12-0223 min
Living Legacy LeadershipDrugs and the FDA Safety, Efficacy & The Public Trust- Miami Book Fair author Dr. Mikkael SekeresDrugs and the FDA: Safety, Efficacy & The Public Trust- Miami Book Fair author Dr. Mikkael Sekeres
Mikkael Sikeres, a respected cancer specialist, professor, author and former chair of the FDA’s drug advisory committee, explores the Food and Drug Administration’s mission, global health crises, patient advocates and politics of the pharmaceutical industry today. While this book primarily tackles the case of the drug Avastin used to treat breast cancer patients, he also covers some inbuilt conflicts of interest between demands for protecting patients and speed of offering potential treatments. Join us to hear if Dr. S...
2022-11-0726 min
New Books in Drugs, Addiction and RecoveryMikkael A. Sekeres, "Drugs and the FDA: Safety, Efficacy, and the Public's Trust" (MIT Press, 2022)How the FDA was shaped by public health crises and patient advocacy, told against a background of the contentious hearings on the breast cancer drug Avastin.Food and Drug Administration approval for COVID-19 vaccines and the controversial Alzheimer's drug Aduhelm made headlines, but few of us know much about how the agency does its work. Why is the FDA the ultimate US authority on a drug's safety and efficacy? In Drugs and the FDA: Safety, Efficacy, and the Public's Trust (MIT Press, 2022), Mikkael Sekeres--a leading oncologist and former chair of the FDA's cancer drug advisory committee--tells the st...
2022-11-0454 min
New Books in Public PolicyMikkael A. Sekeres, "Drugs and the FDA: Safety, Efficacy, and the Public's Trust" (MIT Press, 2022)How the FDA was shaped by public health crises and patient advocacy, told against a background of the contentious hearings on the breast cancer drug Avastin.Food and Drug Administration approval for COVID-19 vaccines and the controversial Alzheimer's drug Aduhelm made headlines, but few of us know much about how the agency does its work. Why is the FDA the ultimate US authority on a drug's safety and efficacy? In Drugs and the FDA: Safety, Efficacy, and the Public's Trust (MIT Press, 2022), Mikkael Sekeres--a leading oncologist and former chair of the FDA's cancer drug advisory committee--tells the st...
2022-11-0458 min
New Books in MedicineMikkael A. Sekeres, "Drugs and the FDA: Safety, Efficacy, and the Public's Trust" (MIT Press, 2022)How the FDA was shaped by public health crises and patient advocacy, told against a background of the contentious hearings on the breast cancer drug Avastin.Food and Drug Administration approval for COVID-19 vaccines and the controversial Alzheimer's drug Aduhelm made headlines, but few of us know much about how the agency does its work. Why is the FDA the ultimate US authority on a drug's safety and efficacy? In Drugs and the FDA: Safety, Efficacy, and the Public's Trust (MIT Press, 2022), Mikkael Sekeres--a leading oncologist and former chair of the FDA's cancer drug advisory committee--tells the st...
2022-11-0458 min
New Books In Public HealthMikkael A. Sekeres, "Drugs and the FDA: Safety, Efficacy, and the Public's Trust" (MIT Press, 2022)How the FDA was shaped by public health crises and patient advocacy, told against a background of the contentious hearings on the breast cancer drug Avastin.Food and Drug Administration approval for COVID-19 vaccines and the controversial Alzheimer's drug Aduhelm made headlines, but few of us know much about how the agency does its work. Why is the FDA the ultimate US authority on a drug's safety and efficacy? In Drugs and the FDA: Safety, Efficacy, and the Public's Trust (MIT Press, 2022), Mikkael Sekeres--a leading oncologist and former chair of the FDA's cancer drug advisory committee--tells the st...
2022-11-0457 min
New Books in American PoliticsMikkael A. Sekeres, "Drugs and the FDA: Safety, Efficacy, and the Public's Trust" (MIT Press, 2022)How the FDA was shaped by public health crises and patient advocacy, told against a background of the contentious hearings on the breast cancer drug Avastin.Food and Drug Administration approval for COVID-19 vaccines and the controversial Alzheimer's drug Aduhelm made headlines, but few of us know much about how the agency does its work. Why is the FDA the ultimate US authority on a drug's safety and efficacy? In Drugs and the FDA: Safety, Efficacy, and the Public's Trust (MIT Press, 2022), Mikkael Sekeres--a leading oncologist and former chair of the FDA's cancer drug advisory committee--tells the st...
2022-11-0458 min
The MIT Press PodcastMikkael A. Sekeres, "Drugs and the FDA: Safety, Efficacy, and the Public's Trust" (MIT Press, 2022)How the FDA was shaped by public health crises and patient advocacy, told against a background of the contentious hearings on the breast cancer drug Avastin.Food and Drug Administration approval for COVID-19 vaccines and the controversial Alzheimer's drug Aduhelm made headlines, but few of us know much about how the agency does its work. Why is the FDA the ultimate US authority on a drug's safety and efficacy? In Drugs and the FDA: Safety, Efficacy, and the Public's Trust (MIT Press, 2022), Mikkael Sekeres--a leading oncologist and former chair of the FDA's cancer drug advisory committee--tells the st...
2022-11-0454 min
Seize the Moment PodcastMikkael Sekeres - Big Pharma vs the FDA - The Avastin Trial | STM Podcast #150On episode 150, we welcome Dr. Mikkael Sekeres to discuss the social and political climate that fostered the necessity to create the FDA, medical charlatans and the history of pseudo-medicine, the necessity of clinical trials for creating safe and effective medications, why anecdotal evidence isn't equivalent to scientific validation, the FDA's decision to remove the breast cancer indication for the drug Avastin and Genentech's decision to fight it, Mikkael's personal experience during that hearing while a member of the jury, the public's distrust of the FDA and where it stems from, Genentech spin-doctoring data to make their case for the...
2022-10-301h 05
Healthcare UnfilteredEpisode 102: Drugs and the FDA: A New Book With Mikkael SekeresRecurring guest Mikkael A. Sekeres, MD, Professor of Medicine and Chief of the Division of Hematology, Sylvester Comprehensive Cancer Center, is today’s guest of honor to discuss and spotlight his just-published book: Drugs and the FDA: Safety, Efficacy, and the Public's Trust. Dr. Sekeres begins by sharing an anecdote of his experience on the FDA Oncologic Drugs Advisory Committee (ODAC) for Avastin as an inspiration to write the book. Then, he delves into the detailed process of becoming an ODAC member and how conflicts of interest are handled in the screening process, how personal experience bias (rather than da...
2022-10-041h 08
The Readout Loud228: A surprise success in Alzheimer's and how FDA history seeded modern controversyLecanemab, a new Alzheimer's treatment from partners Biogen and Eisai, succeeded in a pivotal clinical trial, and we explain the surprising development and its sweeping implications. Then, oncologist Mikkael Sekeres joins us to talk about his new book, which is a history of the FDA and an insider’s look at one of the agency’s most contentious drug approval hearings.
2022-09-2935 min
JAMA Clinical ReviewsDiagnosis and Management of Myelodysplastic SyndromesMyelodysplastic neoplasms, or myelodysplastic syndromes, are diagnosed in approximately 4 of 100 000 people each year in the US and are associated with a 5-year survival rate of approximately 37%. In this JAMA podcast and author interview, JAMA Deputy Editor Mary M. McDermott, MD, discusses the diagnosis and treatment of myelodysplastic syndromes with Mikkael A. Sekeres, MD, MS, chief of hematology and professor of medicine of the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine. Related Content: Diagnosis and Treatment of Myelodysplastic Syndromes
2022-09-0622 min
HCPLive PodcastsRare Disease Report: Myelodysplastic Syndromes & Acute Myeloid LeukemiaMikkael Sekeres, MD, is no stranger to rare disease. In his own words, there are rare diseases and then there are very rare diseases. Sickle cell is a rare condition with an incidence rate of just over 100 per 100,000 people. Sekeres focuses much of his treatment on patients with bone marrow disorders like myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). These conditions have an incidence rate of approximately 5 per 100,000.
In this episode he shares insight on treatment practices, clinical trial procedures and hurdles, as well as the importance of finding reliable sources for information.
2022-06-0322 minLiving Legacy LeadershipSeeing Spirit, Utter Humanity & God in his Blood Cancer Patients: by Miami Book Fair Author Mikkael SekeresSeeing Spirit, Utter Humanity & God in his Blood Cancer Patients: by Miami Book Fair Author Mikkael Sekeres
In his celebrated book, When Blood Breaks Down: Life Lessons from Leukemia, Mikkael Sekeres tells the compelling stories of three people who receive diagnoses of adult leukemia within hours of each other. We join the intimacy of the conversations Sekeres has with his patients and listen in as he teaches trainees. Along the way, he also explores leukemia in its different and complex forms as well as the development of drugs to treat it - describing, among many...
2021-11-1527 min
Taking A Leap -- Deborah BrownMiami Book Fair Author of "When Blood Breaks Down: Life Lessons from Leukemia"Miami Book Fair Author of "When Blood Breaks Down: Life Lessons from Leukemia"
Dr. Mikkael A. Sekeres joined the University of Miami Health System and Sylvester Comprehensive Cancer Center as Chief of the Division of Hematology with a focus on Leukemia and Myeloid Disorders. He earned his medical degree and a Master’s Degree in clinical epidemiology from the University of Pennsylvania School of Medicine. Dr. Sekeres completed his postgraduate training at Harvard University, finishing an internal medicine residency at Massachusetts General Hospital and a fellowship in hematology-oncology at the Dana Farber Cancer Instit...
2021-11-1023 minTaking A Leap -- Deborah BrownMiami Book Fair Author of "When Blood Breaks Down: Life Lessons from Leukemia"Miami Book Fair Author of "When Blood Breaks Down: Life Lessons from Leukemia"
Dr. Mikkael A. Sekeres joined the University of Miami Health System and Sylvester Comprehensive Cancer Center as Chief of the Division of Hematology with a focus on Leukemia and Myeloid Disorders. He earned his medical degree and a Master’s Degree in clinical epidemiology from the University of Pennsylvania School of Medicine. Dr. Sekeres completed his postgraduate training at Harvard University, finishing an internal medicine residency at Massachusetts General Hospital and a fellowship in hematology-oncology at the Dana Farber Cancer Instit...
2021-10-1123 min
Beyond the Journal (Audio)Dr. Mikkael Sekeres, on the Adventures of a Midcareer Move and the Art of the Clinical Narrative | BTJ-023Dr. Mikkael Sekeres of Univ of Miami chats with Charu Aggarwal and Jack West about challenges and opportunities with his move from Cleveland to Miami, his commitment to writing for a broad audience, & challenges for MDs & patients in the wake of COVID-19.
2021-09-2146 min
Healthcare UnfilteredEpisode 48: Mid-Career Academic Transitions with Mikkael Sekeres and David SteensmaMikkael Sekeres (@MikkaelSekeres), MD, chief of the division of hematology at the University of Miami Sylvester Comprehensive Cancer Center, and David Steensma (@DavidSteensma), MD, global hematology head at Novartis, share their recent experiences undergoing career transitions. The physicians dive into a discussion on how often fellowships are given to candidates who are pursuing academic careers, how and why the decisions were made to leave one institution for another (or an institution for industry), whether or not to interview for new positions discreetly, how to approach negotiating aspects of a new employment contract, and so much more.Read Dr. Sekeres...
2021-09-141h 14
Beyond the JournalDr. Mikkael Sekeres, on the Adventures of a Midcareer Move and the Art of the Clinical Narrative | BTJ-023Dr. Mikkael Sekeres of Univ of Miami chats with Charu Aggarwal and Jack West about challenges and opportunities with his move from Cleveland to Miami, his commitment to writing for a broad audience, & challenges for MDs & patients in the wake of COVID-19.
2021-09-1446 min
CME/CEA Novel Therapeutic Approach in Myeloid Malignancies: Targeting the Neddylation Pathway
Host: Jennifer Caudle, DO
Guest: Mikkael A. Sekeres, MD, MS
Guest: Sara M. Tinsley, PhD, ARNP, AOCNP
Please note: This activity is no longer available for continuing education credit. There is a lack of available therapeutic options for the management of patients with myeloid malignancies, including myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML). Novel therapeutic approaches are being evaluated, particularly those that target the NEDD8-activating enzyme (NAE). Evaluating the rationale for NAE inhibition, assessing emerging safety and efficacy data on use of NAE inhibitors in myeloid malignancies, and...
2021-08-3100 minCMEA Novel Therapeutic Approach in Myeloid Malignancies: Targeting the Neddylation Pathway
Host: Jennifer Caudle, DO
Guest: Mikkael A. Sekeres, MD, MS
Guest: Sara M. Tinsley, PhD, ARNP, AOCNP
Please note: This activity is no longer available for continuing education credit. There is a lack of available therapeutic options for the management of patients with myeloid malignancies, including myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML). Novel therapeutic approaches are being evaluated, particularly those that target the NEDD8-activating enzyme (NAE). Evaluating the rationale for NAE inhibition, assessing emerging safety and efficacy data on use of NAE inhibitors in myeloid malignancies, and...
2021-08-3128 minCMEA Novel Therapeutic Approach in Myeloid Malignancies: Targeting the Neddylation Pathway
Host: Jennifer Caudle, DO
Guest: Mikkael A. Sekeres, MD, MS
Guest: Sara M. Tinsley, PhD, ARNP, AOCNP
Please note: This activity is no longer available for continuing education credit. There is a lack of available therapeutic options for the management of patients with myeloid malignancies, including myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML). Novel therapeutic approaches are being evaluated, particularly those that target the NEDD8-activating enzyme (NAE). Evaluating the rationale for NAE inhibition, assessing emerging safety and efficacy data on use of NAE inhibitors in myeloid malignancies, and...
2021-08-3128 minCME/CEA Novel Therapeutic Approach in Myeloid Malignancies: Targeting the Neddylation Pathway
Host: Jennifer Caudle, DO
Guest: Mikkael A. Sekeres, MD, MS
Guest: Sara M. Tinsley, PhD, ARNP, AOCNP
Please note: This activity is no longer available for continuing education credit. There is a lack of available therapeutic options for the management of patients with myeloid malignancies, including myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML). Novel therapeutic approaches are being evaluated, particularly those that target the NEDD8-activating enzyme (NAE). Evaluating the rationale for NAE inhibition, assessing emerging safety and efficacy data on use of NAE inhibitors in myeloid malignancies, and...
2021-08-3128 min
New Books in Biology and EvolutionMikkael A. Sekeres, "When Blood Breaks Down: Life Lessons from Leukemia" (MIT Press, 2020)When you are told that you have leukemia, your world stops. Your brain can't function. You are asked to make decisions about treatment almost immediately, when you are not in your right mind. And yet you pull yourself together and start asking questions. Beside you is your doctor, whose job it is to solve the awful puzzle of bone marrow gone wrong. The two of you are in it together. In When Blood Breaks Down: Life Lessons from Leukemia (MIT Press, 2020), Mikkael Sekeres, a leading cancer specialist, takes readers on the journey that patient and doctor travel together....
2021-08-1658 min
New Books in ScienceMikkael A. Sekeres, "When Blood Breaks Down: Life Lessons from Leukemia" (MIT Press, 2020)When you are told that you have leukemia, your world stops. Your brain can't function. You are asked to make decisions about treatment almost immediately, when you are not in your right mind. And yet you pull yourself together and start asking questions. Beside you is your doctor, whose job it is to solve the awful puzzle of bone marrow gone wrong. The two of you are in it together. In When Blood Breaks Down: Life Lessons from Leukemia (MIT Press, 2020), Mikkael Sekeres, a leading cancer specialist, takes readers on the journey that patient and doctor travel together....
2021-08-1658 minNew Books in MedicineMikkael A. Sekeres, "When Blood Breaks Down: Life Lessons from Leukemia" (MIT Press, 2020)When you are told that you have leukemia, your world stops. Your brain can't function. You are asked to make decisions about treatment almost immediately, when you are not in your right mind. And yet you pull yourself together and start asking questions. Beside you is your doctor, whose job it is to solve the awful puzzle of bone marrow gone wrong. The two of you are in it together. In When Blood Breaks Down: Life Lessons from Leukemia (MIT Press, 2020), Mikkael Sekeres, a leading cancer specialist, takes readers on the journey that patient and doctor travel together....
2021-08-161h 00Cancer Stories: The Art of OncologyTrying To Remember How We Saw Patients on That April MorningIn "Trying To Remember How We Saw Patients on That April Morning" by Mikkael Sekeres, an oncologist reflects on virtual visits during the COVID-19 pandemic. TRANSCRIPT SPEAKER 1: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.
2021-03-2224 min
Connect to Best-Selling Audiobooks in High QualityWhen Blood Breaks Down: Life Lessons from Leukemia -- Mikkael A. SekeresPlease visit https://thebookvoice.com/podcasts/1/audiobook/430151 to listen full audiobooks.
Title: When Blood Breaks Down: Life Lessons from Leukemia
Author: Mikkael A. Sekeres
Narrator: Mike Lenz
Format: Unabridged Audiobook
Length: 7 hours 28 minutes
Release date: July 7, 2020
Ratings: Ratings of Book: 5 of Total 1
Genres: History & Culture
Publisher's Summary: When you are told that you have leukemia, your world stops. Your brain can't function. You are asked to make decisions about treatment almost immediately, when you are not in your right mind. And yet you pull yourself together and start asking questions. Beside you...
2020-07-077h 28
Download Top Free Audiobooks in Biography & Memoir, History & CultureWhen Blood Breaks Down: Life Lessons from Leukemia by Mikkael A. SekeresPlease visit https://thebookvoice.com/podcasts/1/audiobook/430151 to listen full audiobooks. Title: When Blood Breaks Down: Life Lessons from Leukemia Author: Mikkael A. Sekeres Narrator: Mike Lenz Format: Unabridged Audiobook Length: 7 hours 28 minutes Release date: July 7, 2020 Ratings: Ratings of Book: 5 of Total 1 Genres: History & Culture Publisher's Summary: When you are told that you have leukemia, your world stops. Your brain can't function. You are asked to make decisions about treatment almost immediately, when you are not in your right mind. And yet you pull yourself together and start asking questions. Beside you is your doctor, whose job it is to...
2020-07-0730 min
Get Lost In This Heart-Pounding Full Audiobook — Perfect Between Meetings.When Blood Breaks Down by Mikkael A. SekeresPlease visithttps://thebookvoice.com/podcasts/2/audible/124663to listen full audiobooks.
Title: When Blood Breaks Down
Author: Mikkael A. Sekeres
Narrator: Mike Lenz
Format: mp3
Length: 7 hrs and 28 mins
Release date: 07-07-20
Ratings: 5 out of 5 stars, 37 ratings
Genres: Physician & Patient
Publisher's Summary:
When you are told that you have leukemia, your world stops. Your brain can't function. You are asked to make decisions about treatment almost immediately, when you are not in your right mind. And yet you pull yourself together and start asking questions. Beside you is your doctor, whose job it is to solve the awful puzzle of...
2020-07-077h 28
The HematologistWhat to Expect at the 60th ASH Annual Meeting With Drs. Hamadani, Sekeres, and Sola-VisnerIn this podcast, 2018 ASH News Daily Editor-in-Chief Dr. Mehdi Hamadani has a conversation with Education Program Co-chair Dr. Mikkael Sekeres and Scientific Program Co-chair Dr. Martha Sola-Visner about what to expect at the 60th ASH Annual Meeting and Exposition, taking place December 1-4, 2018, in San Diego, California. They talk about stimulating sessions to look forward to, new exciting features and features from previous years that are making their return such as Alexa-Ask ASH and Collaboration Rooms, as well as an array of networking events. Attendees will have the opportunity to connect with the top minds in the field of malignant...
2018-11-2127 min
Frankly Speaking About CancerEncore: The Art and Science of Medicine: A Conversation with Dr. Mikkael SekeresHippocrates, the Greek physician who is revered as the father of medicine, said, “The art has three factors: the disease, the patient, the physician.”
2016-07-1255 minFrankly Speaking About CancerThe Art and Science of Medicine: A Conversation with Dr. Mikkael SekeresHippocrates, the Greek physician who is revered as the father of medicine, said, “The art has three factors: the disease, the patient, the physician.”
2016-05-0355 min
Oncology Times - OncTimes TalkA Clinical Research Consortium for MDSMikkael A. Sekeres, MD, MS—who’s co-chairing the unique initiative to bolster research for the rare disease—explains what’s on the agenda and who’s involved.
Hear what he told OT about the $16-million, five-year plan.
2013-08-0704 minOncology Times - OncTimes TalkOT Clinical Advisory Editor for Hematology/Oncology Mikkael Sekeres, MD, MSDr. Sekeres, Director of the Leukemia Program at the Cleveland Clinic Taussig Cancer Institute and Chair of the Hematology/Oncology Pharmacy & Therapeutics Committee, discusses his particular research interests of myelodysplastic syndromes and acute myelogenous leukemia, including the overlaps between the two in older adults, new opportunities to better define MDS epidemiologically in the US, and new treatment approaches.
2010-04-0912 min
OT Broadcast NewsOT Clinical Advisory Editor for Hematology/Oncology Mikkael Sekeres, MD, MSDr. Sekeres, Director of the Leukemia Program at the Cleveland Clinic Taussig Cancer Institute and Chair of the Hematology/Oncology Pharmacy & Therapeutics Committee, discusses his particular research interests of myelodysplastic syndromes and acute myelogenous leukemia, including the overlaps between the two in older adults, new opportunities to better define MDS epidemiologically in the US, and new treatment approaches.
2010-04-0912 min